Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort

Abstract Background The aim of the study was to analyze the relationship between pretreatment inflammatory biomarkers (IBs) and survival outcomes for patients with esophageal squamous cell carcinoma (ESCC) treated with neoadjuvant chemoradiotherapy (neo‐CRT) and pembrolizumab. Methods Clinical varia...

書目詳細資料
發表在:	Thoracic Cancer
Main Authors:	Wei‐Xiang Qi, Xiaoyan Wang, Chengqiang Li, Shuyan Li, Huan Li, Feifei Xu, Jiayi Chen, Shengguang Zhao, Hecheng Li
格式:	Article
語言:	英语
出版:	Wiley 2023-06-01
主題:	absolute lymphocyte count esophageal squamous cell carcinoma neoadjuvant chemoradiotherapy pathological complete response pembrolizumab
在線閱讀:	https://doi.org/10.1111/1759-7714.14898

相似書籍

Characterization and dosimetric predictors for absolute lymphocyte count changes during neoadjuvant chemoradiotherapy with or without pembrolizumab for esophageal squamous cell carcinoma: an analysis of a prospective cohort
由: Wei-Xiang Qi, et al.
出版: (2025-01-01)

The addition of pembrolizumab to neoadjuvant chemoradiotherapy did not increase the risk of developing postoperative anastomotic leakage for ESCC: an analysis from a prospective cohort
由: Wei-Xiang Qi, et al.
出版: (2024-08-01)

Updated protocol of the POINT trial: a multicenter randomized controlled trial investigating effects of preoperative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy
由: Yumeng Cheng, et al.
出版: (2025-10-01)

2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
由: Majeed H Alwan
出版: (2009-06-01)

Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era
由: Wing-Keen Yap, et al.
出版: (2022-11-01)

Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis
由: Dong-Bin Wang, et al.
出版: (2016-01-01)

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node‐negative esophageal carcinoma
由: Hui‐Jiang Gao, et al.
出版: (2020-09-01)

Evaluation of survival and recurrence patterns in esophageal cancer patients with pathological response to neoadjuvant chemoradiotherapy
由: Ali Kermani, et al.
出版: (2020-01-01)

Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma
由: Jun-Peng Lin, et al.
出版: (2025-08-01)

Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study)
由: Hai-Yu Zhou, et al.
出版: (2020-07-01)

The Comparative Effect of Definitive Chemoradiotherapy and Neoadjuvant Chemoradiotherapy Plus Surgery on One-Year Survival Rate of Esophageal Cancer Patients
由: Fatemeh Khanaki, et al.
出版: (2022-12-01)

Neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: a clinical retrospective study
由: Jiazhen Chen, et al.
出版: (2025-08-01)

Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial
由: Magnus Nilsson, et al.
出版: (2022-07-01)

Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
由: Lei Xu, et al.
出版: (2022-11-01)

Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
由: N. A. Maistrenko, et al.
出版: (2017-08-01)

Prognostic role of the pathological status following neoadjuvant chemoradiotherapy and surgery in esophageal squamous cell carcinoma
由: Xiaofeng Duan, et al.
出版: (2025-01-01)

Preliminary study on involving field irradiation radiotherapy in neoadjuvant chemoradiotherapy for esophageal cancer
由: DONG Xiaohuan, LIU Jun, LI Hongxuan, CHENG Yan, LI Yue, YU Wen, CAI Xuwei, FU Xiaolong
出版: (2023-03-01)

Comparison of neoadjuvant chemoradiotherapy versus chemoradiotherapy plus immunotherapy for esophageal squamous cell carcinoma in a real-world multicenter cohort: a propensity score matching study
由: Shuming Shi, et al.
出版: (2024-10-01)

Neoadjuvant chemoimmunotherapy was associated with better short‐term survival of patients with locally advanced esophageal squamous cell carcinoma compared to neoadjuvant chemoradiotherapy
由: Xiaofeng Duan, et al.
出版: (2024-08-01)

Comparison of neoadjuvant chemotherapy or chemoradiotherapy plus immunotherapy for locally resectable esophageal squamous cell carcinoma
由: Guozhen Yang, et al.
出版: (2024-05-01)

Impact of glucocorticoids on the efficacy of neoadjuvant chemoradiotherapy and survival of patients with locally advanced rectal cancer: a retrospective study
由: Xiaoxue Huang, et al.
出版: (2023-03-01)

Response Assessment after Neoadjuvant Chemoradiotherapy in Rectal Cancer
由: Anuradha Chandramohan, et al.
出版: (2025-05-01)

A Phase II Study of Neoadjuvant Chemoradiotherapy with Docetaxel, Cisplatin and 5-FU Followed by Surgical Resection in the Treatment of Locally Advanced Esophagogastric Junction Cancer and Locally Advanced Esophageal Cancer
由: Chien-Chih Chen, et al.
出版: (2024-04-01)

A machine learning approach using 18F-FDG PET and enhanced CT scan-based radiomics combined with clinical model to predict pathological complete response in ESCC patients after neoadjuvant chemoradiotherapy and anti-PD-1 inhibitors
由: Wei-Xiang Qi, et al.
出版: (2024-01-01)

Study of neoadjuvant chemoradiotherapy with combined S-1 and low-dose cisplatin for patients with clinical stage II/III esophageal cancer
由: Kodai Takahashi, et al.
出版: (2018-03-01)

Advantages of nasogastric tube feeding during neoadjuvant concurrent chemoradiotherapy for esophageal cancer: A retrospective study
由: Jie Dong, et al.
出版: (2023-06-01)

The Influence of Neoadjuvant Chemoradiotherapy on Muscle Mass in Patients with Rectal Cancer
由: Gregory Simpson, et al.
出版: (2019-07-01)

Retrospective Evaluation of the Efficacy of Total Neoadjuvant Therapy and Chemoradiotherapy Neoadjuvant Treatment in Relation to Surgery in Patients with Rectal Cancer
由: Lucian Dragoș Bratu, et al.
出版: (2024-04-01)

Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
由: Guihong Liu, et al.
出版: (2024-03-01)

Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study
由: Zhao J, et al.
出版: (2023-08-01)

Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial
由: Jinsong Yang, et al.
出版: (2023-03-01)

MR radiomics predicts pathological complete response of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a multicenter study
由: Yunsong Liu, et al.
出版: (2024-01-01)

Predicting anastomotic leak in patients with esophageal squamous cell cancer treated with neoadjuvant chemoradiotherapy using a nomogram based on CT radiomic and clinicopathologic factors
由: Junfeng Zhao, et al.
出版: (2025-03-01)

Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
由: V. A. Grigorenko, et al.
出版: (2021-07-01)

A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
由: Ding T, et al.
出版: (2021-10-01)

Editorial: The role of adjuvant and neoadjuvant therapy in resectable esophageal cancer
由: Xiaokun Li, et al.
出版: (2025-09-01)

Association of effective dose to immune cells and vertebral marrow dose with hematologic toxicity during neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma
由: Meng Zhang, et al.
出版: (2024-06-01)

Comparative study of neoadjuvant chemoradiotherapy, chemotherapy, and chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma
由: Likun Liu, et al.
出版: (2025-08-01)

Neoadjuvant immune checkpoint inhibitor in combination with chemotherapy or chemoradiotherapy in resectable esophageal cancer: A systematic review and meta-analysis
由: He Wang, et al.
出版: (2022-09-01)

Transcriptional factor regulation network and competitive endogenous RNA (ceRNA) network determining response of esophageal squamous cell carcinomas to neoadjuvant chemoradiotherapy
由: Mingrui Shao, et al.
出版: (2019-03-01)